US FDA proposes restrictions on marketing of IVDs for research/investigation-use only
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has issued draft guidance to clarify how manufacturers should or should not market in vitro diagnostic products that are labelled as "for research use only" (RUO) or "for investigation use only" (IUO).